drugset / Trial / NCT06195124
A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease
Phase 0
Unknown
8 enrolled
Second Affiliated Hospital of Soochow University
Shanghai Regenelead Therapies Co., Ltd. · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A safety study in patients with Parkinson's disease.
Timeline
- Start
- 2023-12
- Primary completion
- 2024-12
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RGL-193 | Unknown | 1.5e+11 vg | — |
| Subject | RGL-193 | Unknown | 5e+11 vg | — |